Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.
about
Structural basis of HIV-1 resistance to AZT by excisionAmino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of human immunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profilesEstimating HIV-1 fitness characteristics from cross-sectional genotype dataData-intensive analysis of HIV mutations.Relative replication fitness of a high-level 3'-azido-3'-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr-->Gly) at codon 69.HIV-1 reverse transcriptase and antiviral drug resistance. Part 2.Genotypic testing for human immunodeficiency virus type 1 drug resistance.Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage therapyThe "Connection" Between HIV Drug Resistance and RNase HInvolvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitorsFitness comparison of thymidine analog resistance pathways in human immunodeficiency virus type 1.Major HIV resistance mutations in untreated Romanian patients.Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistanceA Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.HIV-1 drug resistance mutations: an updated framework for the second decade of HAARTAptamers that recognize drug-resistant HIV-1 reverse transcriptaseThe Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Effect of the human immunodeficiency virus type 1 reverse transcriptase polymorphism Leu-214 on replication capacity and drug susceptibility.Subtype-specific differences in the human immunodeficiency virus type 1 reverse transcriptase connection subdomain of CRF01_AE are associated with higher levels of resistance to 3'-azido-3'-deoxythymidine.Transmitted HIV drug resistance in treatment-naive Romanian patientsIdentification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase.Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitorIn vitro cross-resistance profile of nucleoside reverse transcriptase inhibitor (NRTI) BMS-986001 against known NRTI resistance mutations.The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations.Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapyThymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.Replicative capacity differences of thymidine analog resistance mutations in subtype B and C human immunodeficiency virus type 1.Amino acid residues in HIV-2 reverse transcriptase that restrict the development of nucleoside analogue resistance through the excision pathway.
P2860
Q24596976-44163255-A6B3-4306-92F5-53C22AB9D5D6Q28361269-D400D8B5-2076-4792-8F91-5DC25E4C8CADQ28544753-40490DBB-6348-4B65-8E6D-68F581BFD646Q30887525-00DBA682-9FBC-4076-8A50-842DA31078C2Q33826453-7EB14A86-1DC8-422C-8B0A-ECED46B23F02Q33900459-B2B4EFB8-1332-4761-B3A2-1DAD3EBE93F6Q33906239-C6D2D735-0904-446F-9644-D528AABF563EQ34106209-D9CB6F6A-6C54-4504-86E5-3365EADFD32BQ34313605-52C9B4A1-04B3-47DF-831E-D915B30E87C4Q34717615-9DB95F8C-8CAA-4213-9221-E3D39FBD9C7FQ34717892-0D2FB68E-F29A-457D-8316-6F33AE366E94Q35071197-70B9DD51-C2D5-4F2F-8BF6-B90B9655D949Q35576015-CEA3AAD0-357F-4210-88FF-602DE858B764Q35742512-F4F67AFF-E28C-435C-8320-83F8EA972793Q36175788-95F83306-2333-40B3-9A17-3FFEE30CBE24Q36900010-D58C590F-03D0-4B9C-8FF6-4A85F238B0D7Q36986716-3B6A9961-A793-4EBA-AD7F-51E4E196EFEAQ37018369-39B60628-43FD-40B8-B514-80F49CEF2E68Q37256719-3ED3EFA2-CDE0-4F95-90F8-570032B1B990Q37333826-24387ACD-2622-4F9F-9684-C33A45161A6AQ37495405-204A29B8-C942-4C71-87F7-E44A71D07680Q40013658-D7A10A01-B727-4F4B-A721-600AF2E0063FQ40787173-D8DA75BA-33C2-429A-B01F-B39A69C62AFEQ41820283-59B12BC8-D0A2-4A0C-B4A6-AE98C2B58559Q42117884-92EB3BE5-5A9E-42AD-8FDA-A52E67518E36Q42430831-2645C77C-C56E-46EA-B68F-38C354D7DE42Q42770670-C2CA1F75-FB3B-4D7C-A9AC-FAA9CA243145Q43146308-C9344C4C-5081-4A4D-8F1D-0355212B23E1Q47560712-93C7AD60-3A80-4158-A377-4FA3A153714E
P2860
Mutation patterns of the reverse transcriptase and protease genes in human immunodeficiency virus type 1-infected patients undergoing combination therapy: survey of 787 sequences.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Mutation patterns of the rever ...... rapy: survey of 787 sequences.
@en
Mutation patterns of the rever ...... rapy: survey of 787 sequences.
@nl
type
label
Mutation patterns of the rever ...... rapy: survey of 787 sequences.
@en
Mutation patterns of the rever ...... rapy: survey of 787 sequences.
@nl
prefLabel
Mutation patterns of the rever ...... rapy: survey of 787 sequences.
@en
Mutation patterns of the rever ...... rapy: survey of 787 sequences.
@nl
P2093
P2860
P1476
Mutation patterns of the rever ...... rapy: survey of 787 sequences.
@en
P2093
J A Gastaut
P2860
P304
P407
P577
1999-12-01T00:00:00Z